Gideon Capital Advisors Inc. purchased a new position in shares of Medidata Solutions Inc (NASDAQ:MDSO) during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 3,591 shares of the company’s stock, valued at approximately $263,000.
Several other hedge funds and other institutional investors have also added to or reduced their stakes in MDSO. Principal Financial Group Inc. raised its holdings in shares of Medidata Solutions by 3.5% in the first quarter. Principal Financial Group Inc. now owns 259,770 shares of the company’s stock worth $16,316,000 after buying an additional 8,753 shares during the last quarter. Cornerstone Wealth Management LLC purchased a new position in shares of Medidata Solutions in the second quarter worth $285,000. Janney Montgomery Scott LLC purchased a new position in shares of Medidata Solutions in the second quarter worth $327,000. Massachusetts Financial Services Co. MA raised its holdings in shares of Medidata Solutions by 29.0% in the second quarter. Massachusetts Financial Services Co. MA now owns 288,073 shares of the company’s stock worth $23,208,000 after buying an additional 64,732 shares during the last quarter. Finally, Los Angeles Capital Management & Equity Research Inc. purchased a new position in shares of Medidata Solutions during the second quarter worth $766,000.
Several research analysts recently issued reports on the stock. ValuEngine raised shares of Medidata Solutions from a “hold” rating to a “buy” rating in a report on Thursday, November 1st. JPMorgan Chase & Co. reduced their target price on shares of Medidata Solutions to $74.00 and set a “neutral” rating for the company in a report on Friday, October 19th. Royal Bank of Canada set a $86.00 target price on shares of Medidata Solutions and gave the stock a “buy” rating in a report on Friday, October 19th. Piper Jaffray Companies reduced their target price on shares of Medidata Solutions from $96.00 to $93.00 in a report on Thursday, October 18th. Finally, Zacks Investment Research cut shares of Medidata Solutions from a “hold” rating to a “sell” rating in a report on Tuesday, October 16th. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and seven have given a buy rating to the stock. The stock presently has a consensus rating of “Buy” and an average target price of $85.10.
Medidata Solutions (NASDAQ:MDSO) last issued its earnings results on Thursday, October 18th. The company reported $0.42 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.36 by $0.06. Medidata Solutions had a net margin of 8.43% and a return on equity of 10.70%. The firm had revenue of $163.41 million during the quarter, compared to analysts’ expectations of $162.09 million. During the same quarter last year, the company posted $0.33 earnings per share. The firm’s revenue was up 17.6% compared to the same quarter last year. As a group, equities analysts anticipate that Medidata Solutions Inc will post 0.85 earnings per share for the current fiscal year.
In related news, EVP Michael I. Otner sold 7,030 shares of the firm’s stock in a transaction on Tuesday, October 23rd. The shares were sold at an average price of $69.40, for a total transaction of $487,882.00. Following the sale, the executive vice president now owns 62,548 shares in the company, valued at $4,340,831.20. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, CFO Rouven Bergmann sold 10,000 shares of the firm’s stock in a transaction on Wednesday, November 28th. The shares were sold at an average price of $75.00, for a total transaction of $750,000.00. Following the sale, the chief financial officer now owns 88,862 shares in the company, valued at approximately $6,664,650. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 24,030 shares of company stock worth $1,749,022. 4.70% of the stock is owned by company insiders.
Medidata Solutions Profile
Medidata Solutions, Inc provides cloud-based solutions for life sciences worldwide. It offers the Medidata Clinical Cloud, a platform, pioneering analytics, and clinical technology for the development of new therapies. The company's platform solutions include data capture and management and trial planning and management.
See Also: Buyback For Investors Defined
Receive News & Ratings for Medidata Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medidata Solutions and related companies with MarketBeat.com's FREE daily email newsletter.